Kanji Nakatsu, Professor Emeritus of Pharmacology at Queen’s University, discusses the potential importance of stress proteins in COVID-19 and how the enzyme Heme Oxygenase could be exploited for treatment.
A new petition supporting the recognition and wide availability of Ivermectin for prophylaxis and early outpatient treatment of COVID-19 has officially launched for signatures from the Canadian public. Signatures can be added until December 25, 2021.
In this brief, we recommend that ivermectin should be considered as a suitable candidate for early out-patient treatment for COVID-19, as well as a prophylactic.
ENTER YOUR SEARCH TERMS AND HIT ENTER
